Literature DB >> 22967720

Return to work after stroke: the role of cognitive deficits.

Antonio Arauz.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22967720     DOI： 10.1136/jnnp-2012-303328

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

1.  Sickness absence and return to work among Japanese stroke survivors: a 365-day cohort study.

Authors:  Motoki Endo; Toshimi Sairenchi; Noriko Kojimahara; Yasuo Haruyama; Yasuto Sato; Rika Kato; Naohito Yamaguchi
Journal:  BMJ Open       Date:  2016-01-04       Impact factor: 2.692

2.  Employment sustainability after return to work among Japanese stroke survivors.

Authors:  Motoki Endo; Yasuo Haruyama; Go Muto; Kazuhito Yokoyama; Noriko Kojimahara; Naohito Yamaguchi
Journal:  Int Arch Occup Environ Health       Date:  2018-05-25       Impact factor: 3.015

3.  An individually randomised controlled multi-centre pragmatic trial with embedded economic and process evaluations of early vocational rehabilitation compared with usual care for stroke survivors: study protocol for the RETurn to work After stroKE (RETAKE) trial.

Authors:  Kathryn A Radford; Kristelle Craven; Vicki McLellan; Tracey H Sach; Richard Brindle; Ivana Holloway; Suzanne Hartley; Audrey Bowen; Rory O'Connor; Judith Stevens; Julie Philips; Marion Walker; Jain Holmes; Christopher McKevitt; John Murray; Caroline Watkins; Katie Powers; Angela Shone; Amanda Farrin
Journal:  Trials       Date:  2020-12-09       Impact factor: 2.279

4.  Compromised Motor Dexterity Confounds Processing Speed Task Outcomes in Stroke Patients.

Authors:  Essie Low; Sheila Gillard Crewther; Ben Ong; Diana Perre; Tissa Wijeratne
Journal:  Front Neurol       Date:  2017-09-21       Impact factor: 4.003

5.  Validation of a New Cognitive Screening Method for Stroke Patients.

Authors:  Katri Saar; Hannu Nyrkkö; Asko Tolvanen; Pekka Kuikka; Erja Poutiainen; Tuija Aro
Journal:  Behav Neurol       Date:  2019-11-06       Impact factor: 3.342
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.